{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:18:04Z","timestamp":1756635484389,"version":"3.37.3"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Vincristine (VCR), a microtubule inhibitor that arrests the cell cycle by blocking metaphase of mitosis, is unique among the vinca alkaloids for causing polyneuropathy. Patients with increased risk of VCR neurotoxicity include the elderly and those with prior history of neuropathy-prone medical conditions. Identifying such risk factors prior to the development of neurotoxicity should be a goal prior to VCR administration. Clinicians should obtain a thorough medical and family history of neuropathies in any child scheduled to receive neurotoxic medications to avoid exacerbating an underlying disorder. We report a case of a young child with newly diagnosed medulloblastoma who started treatment on a VCR-containing chemotherapy regimen following surgery and craniospinal radiation. She subsequently developed severe peripheral polyneuropathy and new enhancement of the cranial and nerve roots following a relatively low cumulative dose of VCR and was diagnosed with previously unidentified Charcot\u2013Marie\u2013Tooth disease (CMTD) Type 1A. This case highlights that an evaluation of risk factors should be completed prior to initiation of neurotoxic chemotherapies and advocates for testing for inherited neuropathies such as CMTD even in asymptomatic patients when hereditary neuropathy is suspected.<\/jats:p>","DOI":"10.1093\/nop\/npz002","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T14:06:10Z","timestamp":1552917970000},"page":"179-184","source":"Crossref","is-referenced-by-count":3,"title":["Acute neurotoxicity following vincristine due to Charcot\u2013Marie\u2013Tooth disease in a young child with medulloblastoma"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5701-898X","authenticated-orcid":false,"given":"Trisha","family":"Kissoon","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hematology-Oncology, University of Florida, Gainesville"},{"name":"Department of Neurosurgery, University of Florida, Gainesville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0311-7127","authenticated-orcid":false,"given":"Sridharan","family":"Gururangan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hematology-Oncology, University of Florida, Gainesville"},{"name":"Department of Neurosurgery, University of Florida, Gainesville"},{"name":"Preston A. Wells Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Sladky","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hematology-Oncology, University of Florida, Gainesville"},{"name":"Department of Neurology, University of Florida, Gainesville"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"issue":"1-2","key":"2019072609302610700_CIT0001","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2005.11.014","article-title":"Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease","volume":"242","author":"Weimer","year":"2006","journal-title":"J Neurol Sci"},{"issue":"11","key":"2019072609302610700_CIT0002","first-page":"2416","article-title":"Vincristine-induced peripheral neuropathy in pediatric cancer patients","volume":"6","author":"Mora","year":"2016","journal-title":"Am J Cancer Res"},{"key":"2019072609302610700_CIT0003","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"2019072609302610700_CIT0004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/WCO.0000000000000474","article-title":"New developments in Charcot\u2013Marie\u2013Tooth neuropathy and related diseases","volume":"30","author":"Pareyson","year":"2017","journal-title":"Curr Opin Neurol"},{"issue":"1-2","key":"2019072609302610700_CIT0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jns.2014.10.013","article-title":"Hereditary motor and sensory neuropathies or Charcot\u2013Marie\u2013Tooth diseases: an update","volume":"347","author":"Tazir","year":"2014","journal-title":"J Neurol Sci"},{"article-title":"MR imaging of the cauda equina in Charcot\u2013Marie\u2013Tooth disease","year":"2015","author":"Tatewaki","key":"2019072609302610700_CIT0006"},{"key":"2019072609302610700_CIT0007","article-title":"Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot\u2013Marie\u2013Tooth disease","volume":"2017","author":"Aghajan","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"3","key":"2019072609302610700_CIT0008","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7556\/jaoa.1999.99.3.165","article-title":"Charcot\u2013Marie\u2013Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis","volume":"99","author":"Olek","year":"1999","journal-title":"J Am Osteopath Assoc"},{"issue":"4","key":"2019072609302610700_CIT0009","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00043426-200304000-00010","article-title":"Vincristine-induced neuropathy as the initial presentation of Charcot\u2013Marie\u2013Tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"25","author":"Chauvenet","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"2019072609302610700_CIT0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MPH.0000000000001230","article-title":"Heterozygosity for CMT Type 4 predicts a severe vincristine-induced polyneuropathy phenotype: a case report and review of literature","volume":"41","author":"Sy","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"2019072609302610700_CIT0011","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1096-911X(199604)26:4<280::AID-MPO12>3.0.CO;2-J","article-title":"Vincristine treatment triggering the expression of asymptomatic Charcot\u2013Marie\u2013Tooth disease","volume":"26","author":"Neumann","year":"1996","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"2019072609302610700_CIT0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/08880018809031253","article-title":"Severe vincristine neurotoxicity in a patient with Charcot\u2013Marie\u2013Tooth disease","volume":"5","author":"Dickerhoff","year":"1988","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"2019072609302610700_CIT0013","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/pbc.20123","article-title":"Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor","volume":"43","author":"Schiavetti","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2019072609302610700_CIT0014","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/mpo.10105","article-title":"Vincristine neurotoxicity in the presence of hereditary neuropathy","volume":"40","author":"Trobaugh-Lotrario","year":"2003","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"2019072609302610700_CIT0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jon.12294","article-title":"Spinal nerve root enhancement on MRI scans in children: a review","volume":"26","author":"Kontzialis","year":"2016","journal-title":"J Neuroimaging"},{"issue":"3","key":"2019072609302610700_CIT0016","first-page":"494","article-title":"Charcot\u2013Marie\u2013Tooth disease: extensive cranial nerve involvement on CT and MR imaging","volume":"25","author":"Aho","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"2019072609302610700_CIT0017","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fphar.2017.00086","article-title":"Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review","volume":"8","author":"Kerckhove","year":"2017","journal-title":"Front Pharmacol"},{"issue":"2","key":"2019072609302610700_CIT0018","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1529-8027.2007.00133.x","article-title":"Are platinum-based chemotherapeutic drugs safe for patients with Charcot\u2013Marie\u2013Tooth disease","volume":"12","author":"Yerushalmi","year":"2007","journal-title":"J Peripher Nerv Syst"},{"issue":"8","key":"2019072609302610700_CIT0019","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/acn3.432","article-title":"Caveats in the established understanding of CMT1A","volume":"4","author":"Li","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"2019072609302610700_CIT0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/jhg.2014.102","article-title":"Severe phenotypes in a Charcot\u2013Marie\u2013Tooth 1A patient with PMP22 triplication","volume":"60","author":"Kim","year":"2015","journal-title":"J Hum Genet"},{"issue":"1","key":"2019072609302610700_CIT0021","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10048-012-0313-1","article-title":"Vincristine exacerbates asymptomatic Charcot\u2013Marie\u2013tooth disease with a novel EGR2 mutation","volume":"13","author":"Nakamura","year":"2012","journal-title":"Neurogenetics"},{"key":"2019072609302610700_CIT0022","doi-asserted-by":"crossref","first-page":"16016","DOI":"10.1038\/npjgenmed.2016.16","article-title":"An asymptomatic mutation complicating severe chemotherapy-induced peripheral neuropathy (CIPN): a case for personalised medicine and a zebrafish model of CIPN","volume":"1","author":"Holloway","year":"2016","journal-title":"NPJ Genom Med"},{"issue":"4","key":"2019072609302610700_CIT0023","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/pbc.21221","article-title":"Uneventful administration of vincristine in Charcot\u2013Marie\u2013Tooth disease type 1X","volume":"50","author":"Ajitsaria","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2019072609302610700_CIT0024","first-page":"CD006052","article-title":"Treatment for Charcot\u2013Marie\u2013Tooth disease","author":"Young","year":"2008","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Neuro-Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nop\/article-pdf\/6\/3\/179\/29006594\/npz002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T09:31:28Z","timestamp":1564133488000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nop\/article\/6\/3\/179\/5373020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,18]]},"published-print":{"date-parts":[[2019,5,7]]}},"URL":"https:\/\/doi.org\/10.1093\/nop\/npz002","relation":{},"ISSN":["2054-2577","2054-2585"],"issn-type":[{"type":"print","value":"2054-2577"},{"type":"electronic","value":"2054-2585"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,3,18]]}}}